A video case study on Cytosponge, a new diagnostic test being introduced by NHS Scotland to identify important oesophageal conditions such as Barrett’s oesophagus.

Identifying cell changes at an early stage is important to ensure conditions such as Barrett’s do not progress to become oesophageal cancer. Screening allows cell changes to be identified and simple, curative treatment to be offered.

The Cytosponge is a small easy to swallow capsule attached to a fine string. After swallowing, the capsule coating dissolves in the stomach to release a small brush which when removed collects cells from the lining of the oesophagus. These cells can then be analysed for abnormalities.

The test has been found in several studies to be a safe, well-tolerated and effective alternative to endoscopy.

This case study provides information on the innovative Cytosponge and the benefits it can bring to patients.

More information on Cytosponge can be found here and here.

An accessible transcript can be found below as an attachment.

Supporting documents